JPY 2343.0
(-0.26%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 50.18 Billion JPY | 1.4% |
2022 | 49.48 Billion JPY | 17.42% |
2021 | 42.14 Billion JPY | 6.34% |
2020 | 39.63 Billion JPY | -9.49% |
2019 | 43.79 Billion JPY | -0.63% |
2018 | 44.07 Billion JPY | -4.68% |
2017 | 46.23 Billion JPY | -0.98% |
2016 | 46.69 Billion JPY | 4.81% |
2015 | 44.54 Billion JPY | 4.72% |
2014 | 42.53 Billion JPY | -2.53% |
2013 | 43.64 Billion JPY | 22.16% |
2012 | 35.72 Billion JPY | 3.12% |
2011 | 34.64 Billion JPY | 11.51% |
2010 | 31.07 Billion JPY | 13.15% |
2009 | 27.46 Billion JPY | 8.06% |
2008 | 25.41 Billion JPY | -6.64% |
2007 | 27.22 Billion JPY | -4.91% |
2006 | 28.62 Billion JPY | -0.47% |
2005 | 28.76 Billion JPY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 15.97 Billion JPY | 26.5% |
2023 Q1 | 13.73 Billion JPY | 12.19% |
2023 FY | 50.18 Billion JPY | 1.4% |
2023 Q3 | 15.82 Billion JPY | 18.84% |
2023 Q2 | 13.31 Billion JPY | -3.02% |
2023 Q4 | 12.63 Billion JPY | -20.18% |
2022 Q3 | 12.91 Billion JPY | 2.63% |
2022 Q1 | 11.75 Billion JPY | 13.85% |
2022 FY | 49.48 Billion JPY | 17.42% |
2022 Q4 | 12.23 Billion JPY | -5.22% |
2022 Q2 | 12.58 Billion JPY | 7.07% |
2021 Q3 | 11.68 Billion JPY | 7.72% |
2021 FY | 42.14 Billion JPY | 6.34% |
2021 Q1 | 9.29 Billion JPY | 1.2% |
2021 Q2 | 10.84 Billion JPY | 16.62% |
2021 Q4 | 10.32 Billion JPY | -11.63% |
2020 Q3 | 11.28 Billion JPY | 16.39% |
2020 FY | 39.63 Billion JPY | -9.49% |
2020 Q1 | 9.45 Billion JPY | -7.76% |
2020 Q4 | 9.18 Billion JPY | -18.61% |
2020 Q2 | 9.69 Billion JPY | 2.56% |
2019 Q4 | 10.25 Billion JPY | -12.94% |
2019 Q3 | 11.77 Billion JPY | 7.86% |
2019 Q2 | 10.91 Billion JPY | 0.71% |
2019 FY | 43.79 Billion JPY | -0.63% |
2019 Q1 | 10.84 Billion JPY | 5.23% |
2018 FY | 44.07 Billion JPY | -4.68% |
2018 Q4 | 10.3 Billion JPY | -14.98% |
2018 Q3 | 12.11 Billion JPY | 12.59% |
2018 Q2 | 10.76 Billion JPY | -1.15% |
2018 Q1 | 10.88 Billion JPY | 1.77% |
2017 Q4 | 10.69 Billion JPY | -15.06% |
2017 FY | 46.23 Billion JPY | -0.98% |
2017 Q3 | 12.59 Billion JPY | 7.37% |
2017 Q2 | 11.73 Billion JPY | 4.67% |
2017 Q1 | 11.2 Billion JPY | 0.14% |
2016 Q2 | 11.24 Billion JPY | -7.88% |
2016 Q1 | 12.2 Billion JPY | 10.55% |
2016 Q4 | 11.19 Billion JPY | -7.14% |
2016 Q3 | 12.05 Billion JPY | 7.2% |
2016 FY | 46.69 Billion JPY | 4.81% |
2015 Q3 | 12.08 Billion JPY | 6.6% |
2015 Q1 | 10.09 Billion JPY | -5.67% |
2015 FY | 44.54 Billion JPY | 4.72% |
2015 Q4 | 11.04 Billion JPY | -8.63% |
2015 Q2 | 11.33 Billion JPY | 12.33% |
2014 FY | 42.53 Billion JPY | -2.53% |
2014 Q3 | 11.13 Billion JPY | 2.97% |
2014 Q2 | 10.81 Billion JPY | 9.22% |
2014 Q1 | 9.89 Billion JPY | -4.76% |
2014 Q4 | 10.69 Billion JPY | -3.9% |
2013 FY | 43.64 Billion JPY | 22.16% |
2013 Q4 | 10.39 Billion JPY | -13.0% |
2013 Q3 | 11.94 Billion JPY | 17.95% |
2013 Q2 | 10.12 Billion JPY | -9.37% |
2013 Q1 | 11.17 Billion JPY | 24.73% |
2012 Q3 | 9.93 Billion JPY | 15.78% |
2012 Q4 | 8.96 Billion JPY | -9.81% |
2012 Q2 | 8.58 Billion JPY | 3.98% |
2012 FY | 35.72 Billion JPY | 3.12% |
2012 Q1 | 8.25 Billion JPY | 7.9% |
2011 Q1 | 8.58 Billion JPY | 14.13% |
2011 FY | 34.64 Billion JPY | 11.51% |
2011 Q2 | 8.62 Billion JPY | 0.47% |
2011 Q3 | 9.78 Billion JPY | 13.4% |
2011 Q4 | 7.64 Billion JPY | -21.83% |
2010 Q1 | 7 Billion JPY | 3.24% |
2010 Q4 | 7.52 Billion JPY | -6.54% |
2010 Q2 | 8.49 Billion JPY | 21.23% |
2010 FY | 31.07 Billion JPY | 13.15% |
2010 Q3 | 8.05 Billion JPY | -5.2% |
2009 Q4 | 6.78 Billion JPY | -11.8% |
2009 Q3 | 7.69 Billion JPY | 13.4% |
2009 Q2 | 6.78 Billion JPY | 9.44% |
2009 Q1 | 6.19 Billion JPY | 2.12% |
2009 FY | 27.46 Billion JPY | 8.06% |
2008 Q2 | 6.74 Billion JPY | 0.0% |
2008 Q3 | 6.31 Billion JPY | -6.44% |
2008 FY | 25.41 Billion JPY | -6.64% |
2008 Q4 | 6.07 Billion JPY | -3.86% |
2007 FY | 27.22 Billion JPY | -4.91% |
2006 FY | 28.62 Billion JPY | -0.47% |
2005 FY | 28.76 Billion JPY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 48.75 Billion JPY | -2.932% |
Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 97.703% |
Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 73.305% |
Shionogi & Co., Ltd. | 369.08 Billion JPY | 86.404% |
Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -1317.212% |
Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 48.276% |
Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | -31.289% |
Eisai Co., Ltd. | 586.41 Billion JPY | 91.443% |
Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -736.634% |
Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | 36.456% |
Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | 3.627% |
Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -271.246% |
Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -548.505% |
Tsumura & Co. | 68.81 Billion JPY | 27.08% |
Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | -34.387% |
Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | -102.409% |
Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | 38.339% |
Fuji Pharma Co., Ltd. | 16.51 Billion JPY | -203.853% |
KYORIN Holdings, Inc. | 51.4 Billion JPY | 2.371% |
Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -4550.725% |
Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -410.025% |
SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -1037.637% |
MedRx Co., Ltd | 26 Million JPY | -192905.092% |
Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -525.257% |
Solasia Pharma K.K. | 337 Million JPY | -14790.601% |
Modalis Therapeutics Corporation | -731 Thousand JPY | 6864850.205% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | -63.644% |
Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | 7.617% |
Cyfuse Biomedical K.K. | 37.74 Million JPY | -132851.791% |
Toho Holdings Co., Ltd. | 112.98 Billion JPY | 55.586% |
Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -655.788% |